ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,667,000 | +66.9% | 300,507 | +4.2% | 0.00% | +100.0% |
| Q2 2019 | $3,395,000 | -6.2% | 288,460 | +8.8% | 0.00% | 0.0% |
| Q1 2019 | $3,619,000 | +33.1% | 265,174 | -0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,719,000 | -38.7% | 265,238 | -0.5% | 0.00% | 0.0% |
| Q3 2018 | $4,439,000 | +3.0% | 266,589 | -2.3% | 0.00% | 0.0% |
| Q2 2018 | $4,311,000 | +9.5% | 272,860 | -12.0% | 0.00% | 0.0% |
| Q1 2018 | $3,936,000 | +7.4% | 309,915 | -3.2% | 0.00% | 0.0% |
| Q4 2017 | $3,664,000 | -5.1% | 320,029 | +1.5% | 0.00% | 0.0% |
| Q3 2017 | $3,860,000 | +45.2% | 315,156 | +35.7% | 0.00% | 0.0% |
| Q2 2017 | $2,659,000 | -39.3% | 232,287 | +10.4% | 0.00% | 0.0% |
| Q1 2017 | $4,377,000 | +4.6% | 210,401 | +4.6% | 0.00% | 0.0% |
| Q4 2016 | $4,185,000 | -39.6% | 201,183 | -4.8% | 0.00% | -50.0% |
| Q3 2016 | $6,928,000 | +40.3% | 211,401 | +6.9% | 0.00% | 0.0% |
| Q2 2016 | $4,938,000 | +89.4% | 197,768 | +85.8% | 0.00% | +100.0% |
| Q1 2016 | $2,607,000 | -35.9% | 106,440 | -13.5% | 0.00% | 0.0% |
| Q4 2015 | $4,065,000 | +3.3% | 123,051 | +2.4% | 0.00% | 0.0% |
| Q3 2015 | $3,936,000 | -39.5% | 120,151 | -2.2% | 0.00% | -50.0% |
| Q2 2015 | $6,508,000 | +249.7% | 122,855 | +90.5% | 0.00% | – |
| Q1 2015 | $1,861,000 | +32.5% | 64,506 | +33.6% | 0.00% | – |
| Q4 2014 | $1,404,000 | +174.2% | 48,266 | +19.3% | 0.00% | – |
| Q3 2014 | $512,000 | -66.9% | 40,472 | -47.4% | 0.00% | – |
| Q2 2014 | $1,546,000 | – | 76,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |